SCHEMBL24405802

SCHEMBL24405802

C=Cc1ccc(-n2c(=O)n(C)c3ccccc32)cc1/C=C\C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PGR P06401 1/20 0.40
▸ ESR1 P03372 1/20 0.34
▸ ESRRA P11474 1/20 0.34
▸ ESR2 Q92731 1/20 0.34
▸ AGER Q15109 1/20 0.33
▸ NPEPPS P55786 1/20 0.33
▸ PIK3CD O00329 2/20 0.33
▸ PIK3CA P42336 2/20 0.33
▸ MTOR P42345 2/20 0.33
▸ PIK3CG P48736 2/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ ERCC1 P07992 1/20 0.33
▸ FEN1 P39748 1/20 0.33
▸ ERCC4 Q92889 1/20 0.33
▸ AR P10275 2/20 0.32
▸ PARG Q86W56 1/20 0.32
▸ TP53 P04637 2/20 0.32
▸ GRM4 Q14833 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24405899 0.80 PGR (0.37) PGRAGERNPEPPSPIK3CDPIK3CA
SCHEMBL24405371 0.76 PGR (0.36) PGRPIK3CDPIK3CAMTORPIK3CG
SCHEMBL23616489 0.72 KDM4E (0.43) ALDH1A1TP53ATMMAPT
SCHEMBL24405760 0.70 MCHR1 (0.43) PGRNPEPPSPIK3CDPIK3CAMTOR
SCHEMBL23784500 0.69 DNM1 (0.33) MTORALDH1A1LMNASMN1; SMN2MAPT
SCHEMBL24405846 0.69 PGR (0.37) PGRNPEPPSPIK3CAMTORALDH1A1
SCHEMBL6362809 0.69 PGR (0.68) PGRALDH1A1LMNASMN1; SMN2PARG
SCHEMBL15082037 0.68 PGR (0.53) PGRPIK3CDPIK3CAMTORPIK3CG
SCHEMBL15396388 0.67 PGR (0.51) PGRNPEPPSALDH1A1LMNASMN1; SMN2
SCHEMBL24405685 0.66 NPEPPS (0.46) PGRNPEPPSALDH1A1SMN1; SMN2AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3774739-B1 FUSED CYCLIC UREA DERIVATIVES AS CRHR2 ANTAGONIST RAQUALIA PHARMA INC (JP) 2022-05-11 — — EP disclosed
Send feedback